Literature DB >> 27030528

Kidney cancer: Recurrence in renal cell carcinoma: the work is not done.

Maxine Sun1, Toni K Choueiri2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27030528     DOI： 10.1038/nrurol.2016.57

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Benefit-risk analysis: a proposal using quantitative methods.

Authors:  William L Holden; Juhaeri Juhaeri; Wanju Dai
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

2.  Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.

Authors:  Wassim Kassouf; Robert Siemens; Christopher Morash; Louis Lacombe; Michael Jewett; Larry Goldenberg; Joseph Chin; Michael Chetner; Christopher G Wood; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

3.  Kidney cancer, version 3.2015.

Authors:  Robert J Motzer; Eric Jonasch; Neeraj Agarwal; Clair Beard; Sam Bhayani; Graeme B Bolger; Sam S Chang; Toni K Choueiri; Brian A Costello; Ithaar H Derweesh; Shilpa Gupta; Steven L Hancock; Jenny J Kim; Timothy M Kuzel; Elaine T Lam; Clayton Lau; Ellis G Levine; Daniel W Lin; M Dror Michaelson; Thomas Olencki; Roberto Pili; Elizabeth R Plimack; Edward N Rampersaud; Bruce G Redman; Charles J Ryan; Joel Sheinfeld; Brian Shuch; Kanishka Sircar; Brad Somer; Richard B Wilder; Mary Dwyer; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2015-02       Impact factor: 11.908

Review 4.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

5.  Treatment management of small renal masses in the 21st century: a paradigm shift.

Authors:  Maxine Sun; Firas Abdollah; Marco Bianchi; Quoc-Dien Trinh; Claudio Jeldres; Rodolphe Thuret; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Ann Surg Oncol       Date:  2012-02-10       Impact factor: 5.344

Review 6.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

7.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

8.  Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.

Authors:  Fabio A B Schutz; Mark M Pomerantz; Kathryn P Gray; Michael B Atkins; Jonathan E Rosenberg; Michelle S Hirsch; David F McDermott; Megan E Lampron; Gwo-Shu Mary Lee; Sabina Signoretti; Philip W Kantoff; Matthew L Freedman; Toni K Choueiri
Journal:  Lancet Oncol       Date:  2012-12-07       Impact factor: 41.316

9.  Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.

Authors:  Jennifer M Lobo; Marc Nelson; Naveen Nandanan; Tracey L Krupski
Journal:  J Urol       Date:  2016-01-14       Impact factor: 7.450

10.  Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.

Authors:  Sherri M Donat; Mireya Diaz; Jay Todd Bishoff; Jonathan A Coleman; Philipp Dahm; Ithaar H Derweesh; S Duke Herrell; Susan Hilton; Eric Jonasch; Daniel W Lin; Victor E Reuter; Sam S Chang
Journal:  J Urol       Date:  2013-05-07       Impact factor: 7.450
  10 in total
  6 in total

1.  Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC.

Authors:  Xiaolin Wang; Haifei Xu; Zhijun Wu; Xiao Chen; Jiandong Wang
Journal:  Int J Exp Pathol       Date:  2017-04-19       Impact factor: 1.925

2.  Up-Regulation of miR-26a-5p Inhibits E2F7 to Regulate the Progression of Renal Carcinoma Cells.

Authors:  Chuanyu Cheng; Liang Guo; Yaohui Ma; Zhe Wang; Xinpeng Fan; Zhongjie Shan
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

3.  Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.

Authors:  Changqing Mao; Weixin Xu; Weina Ma; Chun Wang; Zhaojiao Guo; Jun Yan
Journal:  Front Oncol       Date:  2021-10-05       Impact factor: 6.244

4.  Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study.

Authors:  Francesco Gatto; Saeed Dabestani; Sinisa Bratulic; Angelo Limeta; Francesca Maccari; Fabio Galeotti; Nicola Volpi; Ulrika Stierner; Jens Nielsen; Sven Lundstam
Journal:  Eur Urol Open Sci       Date:  2022-06-29

5.  Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

Authors:  Sebastian Frees; Ines Breuksch; Tobias Haber; Heide-Katharina Bauer; Claudia Chavez-Munoz; Peter Raven; Igor Moskalev; Ninadh D Costa; Zheng Tan; Mads Daugaard; Joachim W Thüroff; Axel Haferkamp; Dirk Prawitt; Alan So; Walburgis Brenner
Journal:  Oncotarget       Date:  2018-03-02

6.  Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values.

Authors:  Xiaojuan Li; Hao Li; Caihong Yang; Liu Liu; Sisi Deng; Mi Li
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.